Panacea Biotec Limited — Important, 13-02-2025: General Updates

The Board of Directors of Panacea Biotec Pharma Limited has appointed Dr. Sanjay Trehan as a Whole-time Director for a term of three years, effective immediately, pending shareholder approval. Dr. Trehan brings extensive experience, including a Ph.D. from the University of Hawaii and previous roles at Dr. Reddy’s Laboratories. He has been associated with Panacea Biotec since 2004 and currently holds a retainership position with the company.

Additionally, Mr. Rajiv Kumar Sharma has been removed from the Senior Management Personnel category due to a change in internal role and responsibilities. These leadership changes may positively impact the company's strategic management and operational effectiveness, warranting close observation from investors.